These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1371128

  • 1. Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo.
    Bishop DK, Li W.
    J Immunol; 1992 Feb 15; 148(4):1049-54. PubMed ID: 1371128
    [Abstract] [Full Text] [Related]

  • 2. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplantation; 1992 Apr 15; 53(4):849-57. PubMed ID: 1533070
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC, Lancki DW, Moldwin RL, Fitch FW.
    J Immunol; 1986 Feb 15; 136(4):1315-21. PubMed ID: 2935576
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM, Miller JF, Shevach EM.
    J Immunol; 1990 Mar 15; 144(6):2109-16. PubMed ID: 1968924
    [Abstract] [Full Text] [Related]

  • 5. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR, Taylor PA, Fitzsimmons WE, Vallera DA.
    J Immunol; 1994 Aug 15; 153(4):1836-46. PubMed ID: 7519216
    [Abstract] [Full Text] [Related]

  • 6. [Experimental studies on the mode of action of cyclosporine and FK506 assessed by proliferation response of human cloned T lymphocytes].
    Matsuura T, Negita M, Ikegami M, Imanishi M, Nishioka T, Ishii T, Uemura T, Kunikata S, Kanda H, Akiyama T.
    Hinyokika Kiyo; 1991 Oct 15; 37(10):1141-5. PubMed ID: 1721767
    [Abstract] [Full Text] [Related]

  • 7. Limiting dilution analysis for alloreactive, TCGF-secretory T cells. Two related LDA methods that discriminate between unstimulated precursor T cells and in vivo-alloactivated T cells.
    Bishop DK, Orosz CG.
    Transplantation; 1989 Apr 15; 47(4):671-7. PubMed ID: 2523104
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD, Chan SY, Bishop DK.
    Transplantation; 1996 Aug 15; 62(3):388-96. PubMed ID: 8779688
    [Abstract] [Full Text] [Related]

  • 9. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG, Adams PW, Ferguson RM.
    Transplantation; 1988 Aug 15; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [Abstract] [Full Text] [Related]

  • 10. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R, Archibald J, Gress RE.
    J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451
    [Abstract] [Full Text] [Related]

  • 11. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J, Morancho B, Kim SJ, López-Botet M, Aramburu J.
    J Leukoc Biol; 2005 May 01; 77(5):748-58. PubMed ID: 15716327
    [Abstract] [Full Text] [Related]

  • 12. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK, Stohlman SA.
    J Immunol; 1991 May 15; 146(10):3322-31. PubMed ID: 1673982
    [Abstract] [Full Text] [Related]

  • 13. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.
    Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S.
    J Clin Invest; 1995 Aug 15; 96(2):727-32. PubMed ID: 7543492
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
    Nomoto K, Eto M, Yanaga K, Nishimura Y, Maeda T, Nomoto K.
    J Immunol; 1992 Oct 15; 149(8):2668-74. PubMed ID: 1401906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ.
    Transplantation; 1993 Oct 15; 56(4):892-7. PubMed ID: 8212213
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.